MainReads
← Details
Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.
Hermans N, Phelan J, Sorrentino R, Boysen F, Sherry NL, Miotto P, Cirillo DM, Chindelevitch L, Rodwell TC, Barilar I, Niemann S, Andres S, Mischnik A, Horan K, Bond K, Globan M, Rubinstein M, Losev Y, Clark TG, Mitarai S, Iskakova A, Slyzkyi A, Köser CU, Kremer K, Anthony R
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.